Closed

Research Funding Programs

Q: How much funding can be received?

Research Funding Programs Funds up to $750,000 of admissible expenses.

Q: Who is eligible for the Research Funding Programs program?

To be eligible for the Research Funding Programs program, you must: Regenerative medicine research Translational focus Fits an available funding stream

Q: Where is the Research Funding Programs available?

The Research Funding Programs program is available across Canada.

Q: Is the Research Funding Programs a grant, loan, or tax credit?

Research Funding Programs is a Grant and Funding

Q: Who are the financial supporters of the Research Funding Programs?

Research Funding Programs is funded by Stem Cell Network

Last Update: March 3, 2026

Canada

Supports translational regenerative medicine research and clinical advancement

Grant and Funding

Overview

This program supports translational regenerative medicine research with funding up to $750,000. Eligible activities span proof-of-principle experiments, knowledge translation, clinical translation research, early-stage clinical trials, and academic–biotech partnerships.

At a glance

Funding available

Financing goals

Integrate new technologies

Develop strategic partnerships

Develop a new product

Eligible Funding

Maximum amount : 750,000 $

Timeline

Closing date : March 3, 2026

Eligible candidates

Eligible Industries

Professional, scientific and technical services
Health care and social assistance

Location

Canada

Legal structures

Non-profit

Annual revenue

All revenue ranges

Organisation size

All organization sizes

Audience

All groups

Non-profit candidates

Sector of operation

Research

Target groups

All the groups

Revenue structures

All structures

Scope

All dimensions

Activities funded

Proof-of-principle experiments, including novel therapeutic or technical approach development.
Knowledge creation and translation of regenerative medicine research for targeted stakeholders and/or users.
Multi-disciplinary research moving toward the clinic within five years.
Research addressing key questions associated with an ongoing clinical trial.
Early-stage clinical trial projects with high translational potential.

Examples of admissible projects:

$ 735,000

GMP manufacturing and preclinical package for iPSC retinal cell therapy

$ 392,000

Automated closed-system MSC manufacturing validation with academic partnership

Eligibility

The proposed work must be regenerative medicine research.
The project must align with translational objectives across the research continuum.
The activities must fit within one of the program’s five funding streams.

Who is eligible?

Applicants proposing regenerative medicine research projects (including clinical and translational work).
Academic teams partnering with emerging Canadian regenerative medicine biotechnology companies (for the partnership stream).

Eligible geographic areas

Canada (program objectives reference benefits for Canadians).

Additional information

The program offers five distinct funding streams tailored to different stages of regenerative medicine research and translation.
Funding is positioned to support translational research that aims for health, social, and economic benefits for Canadians.
A Letter of Intent stage is referenced, with a past deadline date shown as 2022-09-22.

Apply to this program

Frequently Asked Questions about the Research Funding Programs Program

Here are answers to the most common questions about the Research Funding Programs. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the Research Funding Programs?

How much funding can be received?

Who is eligible for the Research Funding Programs program?

What expenses are eligible under Research Funding Programs?

Proof-of-principle experiments, including novel therapeutic or technical approach development. Knowledge creation and translation of regenerative medicine research for targeted stakeholders and/or users. Multi-disciplinary research moving toward the clinic within five years. Research addressing key questions associated with an ongoing clinical trial. Early-stage clinical trial projects with high translational potential.